Home » Topics » Conferences

Conferences
RSS

CUDC-101 shows good tolerability in first-in-human trial in advanced solid tumors

Dec. 10, 2010

Phase I data presented on volociximab/ranibizumab combination in wet AMD

Dec. 10, 2010

Development of cancer stem cell-targeting agents SL-401 and SL-501 continues

Dec. 10, 2010

ArQule evaluates ARQ-087 in models of cancer

Dec. 9, 2010

ACT Biotech describes unique mechanism of action of ACTB-1003

Dec. 9, 2010

BI-6727 shows promise in phase I/II trial in acute myeloid leukemia

Dec. 9, 2010

Phase I/II data presented on MLN-8237 in hematological malignancies

Dec. 9, 2010

Phase II results for plitidepsin in peripheral T-cell lymphoma presented

Dec. 7, 2010

Activity seen with ARRY-520 in patients with relapsed/refractory multiple myeloma

Dec. 7, 2010

ACT Biotech describes activity of Aurora kinase inhibitor ACTB-1010

Dec. 7, 2010

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...